GSK plc reports developments across its global biopharma business, including vaccines, respiratory medicines, infectious disease, immunology and oncology programs. Recurring updates include regulatory decisions and clinical evidence for products such as AREXVY, GSK's RSV vaccine, and Exdensur for severe asthma, along with data presentations, product indications and therapeutic-area access initiatives.
GSK news also covers manufacturing and supply agreements, commercial collaborations, public-health grant programs and product partnerships tied to its medicine and vaccine portfolio. As an American Depositary Share issuer, company updates may reflect both parent-company announcements and ADR-related market disclosures.
ViiV Healthcare announced the launch of a new weekly podcast titled Being Seen, which explores cultural representations relevant to the queer and gay Black male experience. Hosted by Darnell Moore, the podcast aims to change perceptions and reduce stigma surrounding this community, emphasizing their stories and challenges. Available starting October 6, Being Seen features conversations with various artists and activists. This initiative aligns with ViiV's focus on addressing HIV-related disparities and amplifying marginalized voices in society.
GSK Consumer Healthcare has launched Advil Dual Action, a groundbreaking over-the-counter pain relief formula that combines ibuprofen and acetaminophen, becoming the first FDA-approved of its kind in 25 years. This innovative product targets pain through two mechanisms: directly at the source and by blocking pain signals to the brain. Acclaimed actress Angela Kinsey is the face of the launch, aiming to showcase its efficacy in managing everyday aches and pains. A survey reveals 95% of adults experience pain, with 80% seeking better relief options, highlighting significant market potential for Advil Dual Action.
GSK Consumer Healthcare launched Advil Dual Action, an innovative over-the-counter pain relief solution combining ibuprofen and acetaminophen. This launch follows FDA approval, marking a significant milestone as the first product of its kind in the OTC market. A recent survey revealed that while 95% of Americans experience pain, 80% do not find complete relief with existing medications. Advil aims to enhance pain management discussions with a modern emoji scale for pain representation. Advil Dual Action is available online and in stores nationwide.
On July 14, 2020, GlaxoSmithKline (GSK) announced that the FDA Oncologic Drugs Advisory Committee voted 12-0 in favor of the benefit-risk profile of belantamab mafodotin, an investigational treatment for relapsed or refractory multiple myeloma. The committee recognized its potential for patients who have undergone at least four prior therapies. The recommendation stems from the DREAMM-2 clinical trial. While the FDA may consider this recommendation, it is not obliged to follow it. Belantamab mafodotin is not yet approved worldwide.